Staar Surgical Company (STAA) closed at $25.21 on November 6, 2026, down 5.7% from the previous close, on volume of 986,556 shares (30-day average 660,172).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 5, 2026 | Strangle or Risk Reversal | 18-Dec-2625 P : 27.5 C | 200 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
STAAR Surgical Earnings Call Highlights Growth and Risks
TipRanks (Thu, 5-Nov 7:15 PM ET)
TipRanks (Thu, 5-Nov 5:46 PM ET)
At a glance: stocks gapping up premarket
Seeking Alpha News (Thu, 5-Nov 7:25 AM ET)
STAAR Surgical Reports Third-Quarter 2026 Financial Results
TipRanks (Wed, 4-Nov 5:04 PM ET)
STAAR Surgical Non-GAAP EPS of $0.28 beats by $0.11, revenue of $83.4M beats by $4.67M
Seeking Alpha News (Wed, 4-Nov 4:06 PM ET)
STAAR Surgical Reports Third Quarter 2026 Results
Business Wire (Wed, 4-Nov 4:01 PM ET)
STAAR Surgical Q3 2026 Earnings Preview
Seeking Alpha News (Tue, 3-Nov 5:35 PM ET)
STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
Business Wire (Thu, 29-Oct 7:01 AM ET)
STAAR Surgical to Participate in Upcoming Investor Conferences
Business Wire (Tue, 27-Oct 4:01 PM ET)
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
Staar Surgical Company trades on the NASDAQ stock market under the symbol STAA.
As of November 6, 2026, STAA stock price declined to $25.21 with 986,556 million shares trading.
STAA has a beta of 0.72, meaning it tends to be less sensitive to market movements. STAA has a correlation of 0.03 to the broad based SPY ETF.
STAA has a market cap of $1.26 billion. This is considered a Small Cap stock.
Last quarter Staar Surgical Company reported $83 million in Revenue and $.11 earnings per share. This beat revenue expectation by $4 million and missed earnings estimates by -$.03.
In the last 3 years, STAA traded as high as $52.68 and as low as $13.50.
The top ETF exchange traded funds that STAA belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
STAA has underperformed the market in the last year with a return of -5.3%, while SPY returned +10.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in STAA shares. However, STAA has outperformed the market in the last 3 month and 2 week periods, returning +9.0% and +11.5%, while SPY returned -4.1% and -3.2%, respectively. This indicates STAA has been having a stronger performance recently.
STAA support price is $25.76 and resistance is $27.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STAA shares will trade within this expected range on the day.
